UH-LOGO.png

ULTRAHUMAN

DEVELOPING NOVEL, BEST IN CLASS IMMUNO-ONCOLOGY ANTIBODIES AGAINST CLINICALLY VALIDATED TARGETS USING A PROPRIETARY ENGINEERING PLATFORM.